FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316174652> ?p ?o ?g. }

• W4316174652 endingPage "100771" @default.
• W4316174652 startingPage "100771" @default.
• W4316174652 abstract "Neoadjuvant chemotherapy may improve overall survival (OS) in 'borderline' resectable pancreatic cancer (RPC). Whether the results are the same in upfront RPC is unknown.To evaluate the association of neoadjuvant treatment and survival outcomes in RPC, a systematic literature review was carried out including prospective randomized trials of neoadjuvant treatment versus upfront surgery. Articles indexed in PubMed, Embase and Scopus were evaluated. Data regarding systemic treatment regimens, R0 resection rates, disease-free survival (DFS) and OS were extracted. The outcomes were compared using a random-effects model. The index I2 and the graphs of funnel plot were used for the interpretation of the data.Of 3229 abstracts, 6 randomized controlled trials were considered eligible with a combined sample size of 805 RPC patients. Among the trials, PACT-15, PREP-02/JSAP-05 and updated long-term results from PREOPANC and NEONAX trials were included. Combining the studies with meta-analysis, we could see that neoadjuvant treatment in RPC does not improve DFS [hazard ratio (HR) 0.71 (0.46-1.09)] or OS [HR 0.76 (0.52-1.11)], without significant heterogeneity. Interestingly, R0 rates improved ∼20% with the neoadjuvant approach [HR 1.2 (1.04-1.37)]. It is important to note that most studies evaluated gemcitabine-based regimens in the neoadjuvant setting.Neoadjuvant chemotherapy or chemoradiation does not improve DFS or OS in RPC compared to upfront surgery followed by adjuvant treatment. Neoadjuvant treatment improves R0 rates by ∼20%. Randomized ongoing trials are eagerly awaited with more active combined regimens including modified FOLFIRINOX." @default.
• W4316174652 created "2023-01-15" @default.
• W4316174652 creator A5018257387 @default.
• W4316174652 creator A5039154751 @default.
• W4316174652 creator A5042063856 @default.
• W4316174652 creator A5049970130 @default.
• W4316174652 creator A5052890292 @default.
• W4316174652 creator A5058611909 @default.
• W4316174652 creator A5070991499 @default.
• W4316174652 creator A5076469598 @default.
• W4316174652 date "2023-02-01" @default.
• W4316174652 modified "2023-10-01" @default.
• W4316174652 title "Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival? A systematic review and meta-analysis of randomized controlled trials" @default.
• W4316174652 cites W2125435699 @default.
• W4316174652 cites W2138582833 @default.
• W4316174652 cites W2171853361 @default.
• W4316174652 cites W2755243126 @default.
• W4316174652 cites W2770835903 @default.
• W4316174652 cites W2796434454 @default.
• W4316174652 cites W2903623792 @default.
• W4316174652 cites W2908229190 @default.
• W4316174652 cites W2947818769 @default.
• W4316174652 cites W2947967691 @default.
• W4316174652 cites W2970684805 @default.
• W4316174652 cites W3004017076 @default.
• W4316174652 cites W3008190574 @default.
• W4316174652 cites W3009400989 @default.
• W4316174652 cites W3017314211 @default.
• W4316174652 cites W3028089514 @default.
• W4316174652 cites W3121138383 @default.
• W4316174652 cites W3128646645 @default.
• W4316174652 cites W3138807170 @default.
• W4316174652 cites W3170755985 @default.
• W4316174652 cites W3202823192 @default.
• W4316174652 cites W3204382676 @default.
• W4316174652 cites W3215936496 @default.
• W4316174652 cites W4205349926 @default.
• W4316174652 cites W4213155142 @default.
• W4316174652 cites W4226269919 @default.
• W4316174652 cites W4281786007 @default.
• W4316174652 cites W4285390129 @default.
• W4316174652 cites W4286294596 @default.
• W4316174652 cites W4286298195 @default.
• W4316174652 cites W4290960434 @default.
• W4316174652 cites W4291019296 @default.
• W4316174652 cites W4302774660 @default.
• W4316174652 cites W592682419 @default.
• W4316174652 cites W993424279 @default.
• W4316174652 doi "https://doi.org/10.1016/j.esmoop.2022.100771" @default.
• W4316174652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36638709" @default.
• W4316174652 hasPublicationYear "2023" @default.
• W4316174652 type Work @default.
• W4316174652 citedByCount "5" @default.
• W4316174652 countsByYear W43161746522023 @default.
• W4316174652 crossrefType "journal-article" @default.
• W4316174652 hasAuthorship W4316174652A5018257387 @default.
• W4316174652 hasAuthorship W4316174652A5039154751 @default.
• W4316174652 hasAuthorship W4316174652A5042063856 @default.
• W4316174652 hasAuthorship W4316174652A5049970130 @default.
• W4316174652 hasAuthorship W4316174652A5052890292 @default.
• W4316174652 hasAuthorship W4316174652A5058611909 @default.
• W4316174652 hasAuthorship W4316174652A5070991499 @default.
• W4316174652 hasAuthorship W4316174652A5076469598 @default.
• W4316174652 hasBestOaLocation W43161746521 @default.
• W4316174652 hasConcept C121608353 @default.
• W4316174652 hasConcept C126322002 @default.
• W4316174652 hasConcept C143998085 @default.
• W4316174652 hasConcept C168563851 @default.
• W4316174652 hasConcept C207103383 @default.
• W4316174652 hasConcept C2776694085 @default.
• W4316174652 hasConcept C2777148230 @default.
• W4316174652 hasConcept C2778292576 @default.
• W4316174652 hasConcept C2780210213 @default.
• W4316174652 hasConcept C2780258809 @default.
• W4316174652 hasConcept C2780259306 @default.
• W4316174652 hasConcept C2780439572 @default.
• W4316174652 hasConcept C44249647 @default.
• W4316174652 hasConcept C526805850 @default.
• W4316174652 hasConcept C530470458 @default.
• W4316174652 hasConcept C71924100 @default.
• W4316174652 hasConcept C82605166 @default.
• W4316174652 hasConcept C95190672 @default.
• W4316174652 hasConceptScore W4316174652C121608353 @default.
• W4316174652 hasConceptScore W4316174652C126322002 @default.
• W4316174652 hasConceptScore W4316174652C143998085 @default.
• W4316174652 hasConceptScore W4316174652C168563851 @default.
• W4316174652 hasConceptScore W4316174652C207103383 @default.
• W4316174652 hasConceptScore W4316174652C2776694085 @default.
• W4316174652 hasConceptScore W4316174652C2777148230 @default.
• W4316174652 hasConceptScore W4316174652C2778292576 @default.
• W4316174652 hasConceptScore W4316174652C2780210213 @default.
• W4316174652 hasConceptScore W4316174652C2780258809 @default.
• W4316174652 hasConceptScore W4316174652C2780259306 @default.
• W4316174652 hasConceptScore W4316174652C2780439572 @default.
• W4316174652 hasConceptScore W4316174652C44249647 @default.
• W4316174652 hasConceptScore W4316174652C526805850 @default.
• W4316174652 hasConceptScore W4316174652C530470458 @default.
• W4316174652 hasConceptScore W4316174652C71924100 @default.

• next